{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:24:45Z","timestamp":1758403485657},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1007\/bf02481749","type":"journal-article","created":{"date-parts":[[2006,8,15]],"date-time":"2006-08-15T18:41:35Z","timestamp":1155667295000},"page":"96-103","source":"Crossref","is-referenced-by-count":10,"title":["Negative chronotropic and inotropic effects of class I antiarrhythmic drugs assessed in isolated canine blood-perfused sinoatrial node and papillary muscle preparations"],"prefix":"10.1007","volume":"14","author":[{"given":"Atsushi","family":"Sugiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Takehana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02481749_CR1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"DS Echt","year":"1991","unstructured":"Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW (The CAST Investigators) (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324:781\u2013788","journal-title":"N Engl J Med"},{"key":"BF02481749_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(96)02149-6","volume":"348","author":"AL Waldo","year":"1996","unstructured":"Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 348:7\u201312","journal-title":"Lancet"},{"key":"BF02481749_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1253\/jcj.63.1","volume":"63","author":"I Kodama","year":"1999","unstructured":"Kodama I, Ogawa S, Inoue H, Kasanuki H, Kato T, Mitamura H, Hiraoka M, Sugimoto T. The Guideline Committee for Clinical Use of Antiarrhythmic Drugs in Japan (1999) Profiles of aprindine, cibenzoline, pilsicainide and pirmenol in the framework of the Sicilian Gambit. Jpn Circ J 63:1\u201312","journal-title":"Jpn Circ J"},{"key":"BF02481749_CR4","volume-title":"Antiarrhythmic therapy. A pathophysiological approach","author":"Members of the Sicilian Gambit","year":"1994","unstructured":"Members of the Sicilian Gambit (1994) Antiarrhythmic therapy. A pathophysiological approach. Futura, New York"},{"key":"BF02481749_CR5","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.84.4.1831","volume":"84","author":"Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit","year":"1991","unstructured":"Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit (1991) A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 84:1831\u20131851","journal-title":"Circulation"},{"key":"BF02481749_CR6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1254\/jjp.53.97","volume":"53","author":"A Sugiyama","year":"1990","unstructured":"Sugiyama A, Motomura S, Tamura K, Hashimoto K (1990) Comparison of cardiovascular effects of pirmenol with those of disopyramide in isolated canine heart preparations cross-circulated with a donor dog. Jpn J Pharmacol 53:97\u2013110","journal-title":"Jpn J Pharmacol"},{"key":"BF02481749_CR7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1254\/jjp.66.303","volume":"66","author":"A Sugiyama","year":"1994","unstructured":"Sugiyama A, Motomura S, Hashimoto K (1994) Utilization of an isolated, blood-perfused canine papillary muscle preparation as a model to assess efficacy and adversity of class I antiarrhythmic drugs. Jpn J Pharmacol 66:303\u2013316","journal-title":"Jpn J Pharmacol"},{"key":"BF02481749_CR8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00005344-199102000-00022","volume":"17","author":"K Hashimoto","year":"1991","unstructured":"Hashimoto K, Sugiyama A, Haruno A, Matsuzaki T, Hirasawa A (1991) Effects of new antiarrhythmic drug TYB-3823 on canine ventricular arrhythmia models. J Cardiovasc Pharmacol 17:336\u2013342","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02481749_CR9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/BF00120829","volume":"5","author":"K Hashimoto","year":"1991","unstructured":"Hashimoto K, Haruno A, Matsuzaki T, Sugiyama A, Akiyama K (1991) Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness? Cardiovasc Drugs Ther 5:805\u2013818","journal-title":"Cardiovasc Drugs Ther"},{"key":"BF02481749_CR10","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1152\/ajplegacy.1970.218.5.1459","volume":"218","author":"M Endoh","year":"1970","unstructured":"Endoh M, Hashimoto K (1970) Pharmacological evidence of autonomic nerve activities in canine papillary muscle. Am J Physiol 218:1459\u20131463","journal-title":"Am J Physiol"},{"key":"BF02481749_CR11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00500646","volume":"278","author":"K Kubota","year":"1973","unstructured":"Kubota K, Hashimoto K (1973) Selective stimulation of the parasympathetic preganglionic nerve fibers in the excised and blood-perfused SA node preparation of the dog. Naunyn Schmiedebergs Arch Pharmacol 278:135\u2013150","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BF02481749_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jjp.56.1","volume":"56","author":"A Sugiyama","year":"1991","unstructured":"Sugiyama A, Motomura S, Hashimoto K (1991) Comparison of cardiovascular effects of a novel class Ic antiarrhythmic agent, NIK-244 with those of flecainide in isolated canine heart preparations cross-circulated with a donor dog. Jpn J Pharmacol 56:1\u201312","journal-title":"Jpn J Pharmacol"},{"key":"BF02481749_CR13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/107424849600100308","volume":"1","author":"A Sugiyama","year":"1996","unstructured":"Sugiyama A, Xue YX, Hagihara A, Saitoh M, Hashimoto K (1996) Characterization of magnesium sulfate as an antiarrhythmic agent. J Cardiovasc Pharmacol Ther 1:243\u2013254","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"BF02481749_CR14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/j.1552-4604.1984.tb01822.x","volume":"24","author":"EM Vaughan Williams","year":"1984","unstructured":"Vaughan Williams EM (1984) A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 24:129\u2013147","journal-title":"J Clin Pharmacol"},{"key":"BF02481749_CR15","first-page":"71","volume-title":"Clinical cardiac electrophysiology: techniques and interpretations","author":"ME Josephson","year":"1993","unstructured":"Josephson ME (1993) Sinus node function. In: Josephson ME (ed) Clinical cardiac electrophysiology: techniques and interpretations, 2nd ed. Lea & Febiger, Philadelphia, pp. 71\u201395","edition":"2nd ed."},{"key":"BF02481749_CR16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1536\/ihj.22.929","volume":"22","author":"H Satoh","year":"1981","unstructured":"Satoh H, Nakajima T, Hashimoto K, Imai S (1981) Effects of lidocaine and procaine on the action potential of canine sinus nodal cells. Jpn Heart J 22:929\u2013937","journal-title":"Jpn Heart J"},{"key":"BF02481749_CR17","first-page":"241","volume":"270","author":"H Satoh","year":"1984","unstructured":"Satoh H, Hashimoto K (1984) Effects of lidocaine on membrane currents in rabbit sino-atrial node cells. Arch Int Pharmacodyn Ther 270:241\u2013254","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"BF02481749_CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1254\/jjp.40.83","volume":"40","author":"H Satoh","year":"1986","unstructured":"Satoh H, Hashimoto K (1986) Electrophysiological effects of procaine in rabbit sino-atrial node cells. Jpn J Pharmacol 40:83\u201393","journal-title":"Jpn J Pharmacol"},{"key":"BF02481749_CR19","volume-title":"Basic cardiac electrophysiology for the clinician","author":"J Jalife","year":"1999","unstructured":"Jalife J, Delmer M, Davidenko JM, Anumonwo JMB (1999) Basic cardiac electrophysiology for the clinician. Futura, New York"},{"key":"BF02481749_CR20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF00511411","volume":"332","author":"P Honerj\u00e4ger","year":"1986","unstructured":"Honerj\u00e4ger P, Loibl E, Steidl I, Sch\u00f6nsteiner G, Ulm K (1986) Negative inotropic effects of tetrodotoxin and seven class I antiarrhythmic drugs in relation to sodium channel blockade. Naunyn Schmiedebergs Arch Pharmacol 332:184\u2013195","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BF02481749_CR21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005344-199603000-00007","volume":"27","author":"K Ito","year":"1996","unstructured":"Ito K, Nakafuchi K, Taga A, Yorikane R, Koike H (1996) Possible involvement of altered Na+-Ca2+ exchange in negative inotropic effects of class I antiarrhythmic drugs on rabbit and rat ventricles. J Cardiovasc Pharmacol 27:355\u2013361","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02481749_CR22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00005344-199601000-00008","volume":"27","author":"Y Kihara","year":"1996","unstructured":"Kihara Y, Inoko M, Hatakeyama N, Momose Y, Sasayama S (1996) Mechanisms of negative inotropic effects of class Ic antiarrhythmic agents: comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in dog ventricular myocardium. J Cardiovasc Pharmacol 27:42\u201351","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02481749_CR23","first-page":"347","volume":"32","author":"T Nawada","year":"1994","unstructured":"Nawada T, Tanaka Y, Hirai S, Hisatomi I, Hasegawa J, Kotake H, Mashiba H (1994) Evaluation of negative inotropic and antiarrhythmic effects of class I antiarrhythmic drugs. Int J Clin Pharmacol Ther 32:347\u2013355","journal-title":"Int J Clin Pharmacol Ther"},{"key":"BF02481749_CR24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/01.CIR.28.4.486","volume":"28","author":"DC Harrison","year":"1963","unstructured":"Harrison DC, Sprause JH, Morrow AG (1963) The antiarrhythmic properties of lidocaine and procaine amide. Circulation 28:486\u2013491","journal-title":"Circulation"},{"key":"BF02481749_CR25","doi-asserted-by":"crossref","first-page":"C103","DOI":"10.1152\/ajpcell.1979.236.3.C103","volume":"236","author":"LJ Mullins","year":"1979","unstructured":"Mullins LJ (1979) The generation of electric currents in cardiac fibers by Na\/Ca exchange. Am J Physiol 236:C103\u2013110","journal-title":"Am J Physiol"},{"key":"BF02481749_CR26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1254\/jjp.26.427","volume":"26","author":"N Himori","year":"1976","unstructured":"Himori N, Ono H, Taira N (1976) Simultaneous assessment of effects of coronary vasodilators on the coronary blood flow and the myocardial contractility by using the blood-perfused canine papillary muscle. Jpn J Pharmacol 26:427\u2013435","journal-title":"Jpn J Pharmacol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02481749.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02481749\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02481749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T12:39:00Z","timestamp":1627735140000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02481749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["BF02481749"],"URL":"https:\/\/doi.org\/10.1007\/bf02481749","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,3]]}}}